留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

中国耳念珠菌临床感染现状

徐英春 黄晶晶 肖盟 陈新飞 宁雅婷 范欣 杨洋 冯佳佳 林丽开

徐英春, 黄晶晶, 肖盟, 陈新飞, 宁雅婷, 范欣, 杨洋, 冯佳佳, 林丽开. 中国耳念珠菌临床感染现状[J]. 协和医学杂志, 2019, 10(5): 442-445. doi: 10.3969/j.issn.1674-9081.2019.05.003
引用本文: 徐英春, 黄晶晶, 肖盟, 陈新飞, 宁雅婷, 范欣, 杨洋, 冯佳佳, 林丽开. 中国耳念珠菌临床感染现状[J]. 协和医学杂志, 2019, 10(5): 442-445. doi: 10.3969/j.issn.1674-9081.2019.05.003
Ying-chun XU, Jing-jing HUANG, Meng XIAO, Xin-fei CHEN, Ya-ting NING, Xin FAN, Yang YANG, Jia-jia FENG, Li-kai LIN. Current Status of Clinical Infection of Candida Auris in China[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(5): 442-445. doi: 10.3969/j.issn.1674-9081.2019.05.003
Citation: Ying-chun XU, Jing-jing HUANG, Meng XIAO, Xin-fei CHEN, Ya-ting NING, Xin FAN, Yang YANG, Jia-jia FENG, Li-kai LIN. Current Status of Clinical Infection of Candida Auris in China[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(5): 442-445. doi: 10.3969/j.issn.1674-9081.2019.05.003

中国耳念珠菌临床感染现状

doi: 10.3969/j.issn.1674-9081.2019.05.003
基金项目: 

"艾滋病和病毒性肝炎等重大传染病防治"国家科技重大专项 2018ZX10712001

"精准医学研究"国家重点研发计划 2016YFC0901500

详细信息
    通讯作者:

    林丽开 电话:027-67813059, E-mail:1875278110@qq.com

  • 中图分类号: R519;R446

Current Status of Clinical Infection of Candida Auris in China

More Information
  • 摘要: 耳念珠菌是近年新发现的念珠菌种, 在部分国家尤其是美国呈现耐药性及院内感染暴发态势。"超级病原"及其引申出来的"超级真菌"在真菌领域罕被提及, 但近来"耳念珠菌是超级真菌"的言论却在互联网上广为流传。现有报道及其流行病学监测数据显示, 中国耳念珠菌临床发生发展情况与美国不同, 其所引发的感染仍属个案, 且药物敏感度高, 致病性不强于常见非-白念珠菌。因此, 公众无需过度解读, 以致产生不必要的恐慌。
    利益冲突  无
  • [1] WHO. Antimicrobial resistance: no action today, no cure tomorrow[EB/OL]. https://www.who.int/world-health-day/2011/en/.
    [2] 国家卫生健康委员会.国家卫生健康委办公厅关于持续做好抗菌药物临床应用管理工作的通知[EB/OL]. http://www.nhc.gov.cn/yzygj/s7659/201903/1d487eb7b7c74abc9fcb104f8b0905f2.shtml.
    [3] Satoh K, Makimura K, Hasumi Y, et al. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital[J]. Microbiol Immunol, 2009, 53:41-44. doi:  10.1111/j.1348-0421.2008.00083.x
    [4] US CDC. Global Emergence of Invasive Infections Caused by the Multidrug-Resistant Yeast Candida auris[EB/OL].https://www.cdc.gov/fungal/diseases/candidiasis/candida-auris-alert.html.
    [5] US CDC. Tracking Candida auris [EB/OL]. https://www.cdc.gov/fungal/candida-auris/tracking-c-auris.html.
    [6] Lockhart SR, Etienne KA, Vallabhaneni S, et al. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses[J]. Clin Infect Dis, 2017, 64:134-140. doi:  10.1093/cid/ciw691
    [7] Clancy CJ, Nguyen MH. Emergence of Candida auris:An International Call to Arms[J]. Clin Infect Dis, 2017, 64:141-143. doi:  10.1093/cid/ciw696
    [8] Eyre DW, Sheppard AE, Madder H, et al. A Candida auris Outbreak and Its Control in an Intensive Care Setting[J]. N Engl J Med, 2018, 379:1322-1331. doi:  10.1056/NEJMoa1714373
    [9] Tang HJ, Lai CC, Lai FJ, et al. Emergence of multidrug-resistant Candida auris in Taiwan[J]. Int J Antimicrob Agents, 2019, 53:705-706. doi:  10.1016/j.ijantimicag.2019.02.011
    [10] Chen Y, Zhao J, Han L, et al. Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China[J]. J Infect, 2018, 77:561-571. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=506e946cddd09b4180b73fbd11b6105b
    [11] Tian S, Rong C, Nian H, et al. First cases and risk factors of super yeast Candida auris infection or colonization from Shenyang, China[J]. Emerg Microbes Infect, 2018, 7:128.
    [12] Wang X, Bing J, Zheng Q, et al. The first isolate of Candida auris in China:clinical and biological aspects[J]. Emerg Microbes Infect, 2018, 7:93. https://www.ncbi.nlm.nih.gov/pubmed/29777096
    [13] 郭晶.构建合理用药"金标准":北京协和医院开展临床重要致病性真菌新型诊断技术及全国多中心监测[J].协和医学杂志, 2013, 4:244. http://www.cnki.com.cn/Article/CJFDTotal-XHYX201303009.htm
    [14] Xiao M, Sun ZY, Kang M, et al. Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study[J]. J Clin Microbiol, 2018, 56. pii: e00577-18.
    [15] Wang H, Zhang L, Kudinha T, et al. Investigation of an unrecognized large-scale outbreak of Candida parapsilosis sensu stricto fungaemia in a tertiary-care hospital in China[J]. Sci Rep, 2016, 6:27099. doi:  10.1038/srep27099
    [16] Hou X, Xiao M, Chen SC, et al. Identification and Antifungal Susceptibility Profiles of Candida haemulonii Species Complex Clinical Isolates from a Multicenter Study in China[J]. J Clin Microbiol, 2016, 54:2676-2680. doi:  10.1128/JCM.01492-16
    [17] Adams E, Quinn M, Tsay S, et al. Candida auris in Healthcare Facilities, New York, USA, 2013-2017[J]. Emerg Infect Dis, 2018, 24:1816-1824. doi:  10.3201/eid2410.180649
    [18] Montagna MT, Caggiano G, Lovero G, et al. Epidemiology of invasive fungal infections in the intensive care unit:results of a multicenter Italian survey (AURORA Project)[J]. Infection, 2013, 41:645-653. doi:  10.1007/s15010-013-0432-0
  • 加载中
计量
  • 文章访问数:  1137
  • HTML全文浏览量:  54
  • PDF下载量:  258
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-04-25
  • 刊出日期:  2019-09-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!